BIOMEDITECH ApS — Credit Rating and Financial Key Figures

BIOMEDITECH ApS (CVR number: 34707847) is a company from HERLEV. The company reported a net sales of 0.1 mDKK in 2023, demonstrating a growth of 22.9 % compared to the previous year. The operating profit percentage was at 99.9 % (EBIT: 0.1 mDKK), while net earnings were 186.5 kDKK. The profitability of the company measured by Return on Assets (ROA) was 66 %, which can be considered excellent and Return on Equity (ROE) was 57.2 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 89.1 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. BIOMEDITECH ApS's liquidity measured by quick ratio was 1 which is at a modest level. Thus, the company's liquid assets are in relative balance with its short-term liabilities, indicating a moderate liquidity position. While it's likely to meet its current obligations, financial flexibility may be constrained, and unexpected costs could pose challenges.